MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)

May 21, 2019

Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

May 17, 2019

MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank

May 15, 2019

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

May 14, 2019

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

May 10, 2019

MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results

May 8, 2019

MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol “MEDIF”

May 2, 2019

MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors

May 1, 2019

MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer

Apr 29, 2019

MediPharm Labs Announces DTC Eligibility, Increasing Accessibility for US Investors

Apr 16, 2019